Drug Interactions between Proleukin and vinblastine
This report displays the potential drug interactions for the following 2 drugs:
- Proleukin (aldesleukin)
- vinblastine
Interactions between your drugs
vinBLAStine aldesleukin
Applies to: vinblastine and Proleukin (aldesleukin)
GENERALLY AVOID: Aldesleukin in combination with certain antineoplastic agents (cisplatin, dacarbazine, vinblastine) has been associated with fatal tumor lysis syndrome. Symptoms include hyperkalemia, hyperphosphatasemia, hyperuricemia, hypocalcemia, and acute renal failure. In addition, hypersensitivity reactions requiring medical intervention have been reported with the use of sequential high-dose aldesleukin and dacarbazine or cisplatin. Symptoms occurred within a few hours after chemotherapy administration and included erythema, pruritus, and hypotension.
MANAGEMENT: Concomitant use is not recommended.
References
- (2001) "Product Information. Proleukin (aldesleukin)." Chiron Therapeutics
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Canadian Pharmacists Association (2006) e-CPS. http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink
- Agencia EspaƱola de Medicamentos y Productos Sanitarios Healthcare (2008) Centro de informaciĆ³n online de medicamentos de la AEMPS - CIMA. https://cima.aemps.es/cima/publico/home.html
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.